Kanya Rajangam
2021 - Nkarta
In 2021, Kanya Rajangam earned a total compensation of $2.6M as Chief Medical Officer at Nkarta, a 83% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,480 |
|---|---|
| Option Awards | $1,957,603 |
| Salary | $446,200 |
| Other | $8,700 |
| Total | $2,590,983 |
Rajangam received $2M in option awards, accounting for 76% of the total pay in 2021.
Rajangam also received $178.5K in non-equity incentive plan, $446.2K in salary and $8.7K in other compensation.
Rankings
In 2021, Kanya Rajangam's compensation ranked 5,022nd out of 12,415 executives tracked by ExecPay. In other words, Rajangam earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,022 out of 12,415 | 60th |
Division Manufacturing | 2,114 out of 5,505 | 62nd |
Major group Chemicals And Allied Products | 903 out of 2,375 | 62nd |
Industry group Drugs | 808 out of 2,096 | 62nd |
Industry Pharmaceutical Preparations | 577 out of 1,546 | 63rd |
Source: SEC filing on April 21, 2022.
Rajangam's colleagues
We found two more compensation records of executives who worked with Kanya Rajangam at Nkarta in 2021.